[Establishment of a graft-versus-host disease mouse model for haplo-identical bone marrow transplantation with busulfan and fludarabine conditioning regimen].
作者信息
Li Nainong, Hu Wanyu, Li Xiaofan, Yang Wen, Chen Ping, Chen Yuanzhong
机构信息
Department of Hematology, Fujian Institute of Hematology, Fujian Provincial Key Laboratory of Hematoloy, Fujian Medical University Union Hospital, Fuzhou 350000, China.
出版信息
Zhonghua Xue Ye Xue Za Zhi. 2015 Mar;36(3):238-40. doi: 10.3760/cma.j.issn.0253-2727.2015.03.014.
Abstract
摘要
相似文献
1
[Establishment of a graft-versus-host disease mouse model for haplo-identical bone marrow transplantation with busulfan and fludarabine conditioning regimen].
Zhonghua Xue Ye Xue Za Zhi. 2015 Mar;36(3):238-40. doi: 10.3760/cma.j.issn.0253-2727.2015.03.014.
2
Conditioning with Fludarabine-Busulfan versus Busulfan-Cyclophosphamide Is Associated with Lower aGVHD and Higher Survival but More Extensive and Long Standing Bone Marrow Damage.
Biomed Res Int. 2016;2016:3071214. doi: 10.1155/2016/3071214. Epub 2016 Oct 24.
3
Thiotepa, Busulfan, and Fludarabine Conditioning Regimen in T Cell-Replete HLA-Haploidentical Hematopoietic Stem Cell Transplantation.
Biol Blood Marrow Transplant. 2019 Jul;25(7):1407-1415. doi: 10.1016/j.bbmt.2019.02.025. Epub 2019 Mar 11.
4
Reduced-intensity conditioning with fludarabine and busulfan versus fludarabine and melphalan for patients with acute myeloid leukemia: a report from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
Cancer. 2015 Apr 1;121(7):1048-55. doi: 10.1002/cncr.29163. Epub 2014 Nov 25.
5
Fludarabine and once-daily intravenous busulfan for allogeneic bone marrow transplantation for Chediak-Higashi syndrome.
J Pediatr Hematol Oncol. 2003 Oct;25(10):824-6. doi: 10.1097/00043426-200310000-00019.
6
Thiotepa, busulfan and fludarabine compared to busulfan and cyclophosphamide as conditioning regimen for allogeneic stem cell transplant from matched siblings and unrelated donors for acute myeloid leukemia.
Am J Hematol. 2018 Oct;93(10):1211-1219. doi: 10.1002/ajh.25225. Epub 2018 Aug 15.
7
Comparison of Different Conditioning Regimens of Haploidentical Hematopoietic Stem Cell Transplant in Patients With Acute Myeloid Leukemia.
Exp Clin Transplant. 2018 Dec;16(6):736-744. doi: 10.6002/ect.2017.0100. Epub 2018 May 23.
8
A fludarabine-based dose-reduced conditioning regimen followed by allogeneic stem cell transplantation from related or unrelated donors in patients with myelodysplastic syndrome.
Bone Marrow Transplant. 2001 Oct;28(7):643-7. doi: 10.1038/sj.bmt.1703215.
9
Unrelated-donor bone marrow transplantation with a conditioning regimen including fludarabine, busulfan, and 4 Gy total body irradiation.
Int J Hematol. 2007 Apr;85(3):256-63. doi: 10.1532/IJH97.06199.
10
Haploidentical transplantation is associated with better overall survival when compared to single cord blood transplantation: an EBMT-Eurocord study of acute leukemia patients conditioned with thiotepa, busulfan, and fludarabine.
J Hematol Oncol. 2018 Aug 30;11(1):110. doi: 10.1186/s13045-018-0655-8.
本文引用的文献
1
Current issues in chronic graft-versus-host disease.
Blood. 2014 Jul 17;124(3):374-84. doi: 10.1182/blood-2014-01-514752. Epub 2014 Jun 9.
2
Busulfan plus fludarabine as a myeloablative conditioning regimen compared with busulfan plus cyclophosphamide for acute myeloid leukemia in first complete remission undergoing allogeneic hematopoietic stem cell transplantation: a prospective and multicenter study.
J Hematol Oncol. 2013 Feb 8;6:15. doi: 10.1186/1756-8722-6-15.
3
[Building of hematopoietic stem cell transplantation system with Chinese characteristics].
Zhonghua Xue Ye Xue Za Zhi. 2012 Aug;33(8):601-2.
4
Host APCs augment in vivo expansion of donor natural regulatory T cells via B7H1/B7.1 in allogeneic recipients.
J Immunol. 2011 Mar 1;186(5):2739-49. doi: 10.4049/jimmunol.1002939. Epub 2011 Jan 24.
5
Anti-CD3 preconditioning separates GVL from GVHD via modulating host dendritic cell and donor T-cell migration in recipients conditioned with TBI.
Blood. 2009 Jan 22;113(4):953-62. doi: 10.1182/blood-2008-06-165522. Epub 2008 Oct 15.
6
GVHD after chemotherapy conditioning in allogeneic transplanted mice.
Bone Marrow Transplant. 2008 Dec;42(12):807-18. doi: 10.1038/bmt.2008.261. Epub 2008 Sep 29.
7
Donor CD8+ T cells mediate graft-versus-leukemia activity without clinical signs of graft-versus-host disease in recipients conditioned with anti-CD3 monoclonal antibody.
J Immunol. 2007 Jan 15;178(2):838-50. doi: 10.4049/jimmunol.178.2.838.
8
Target antigens determine graft-versus-host disease phenotype.
J Immunol. 2004 Nov 1;173(9):5467-75. doi: 10.4049/jimmunol.173.9.5467.
Zotero 插件